Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Multiple Myeloma 2Whooping Cough 1Pneumococcal Infections 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Measles 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma 1Immunoblastic Lymphadenopathy 1Hodgkin Disease 1Hepatitis B 1HIV Infections 1

Interventions

Cyclophosphamide 8Peripheral Blood Stem Cell Transplantation 7Busulfan 6Antilymphocyte Serum 6fludarabine phosphate 5Methylprednisolone 4Methotrexate 4Filgrastim 4Cyclosporine 4Psychiatric Rehabilitation 3Whole-Body Irradiation 2Therapeutics 2Tacrolimus 2Radiotherapy 2Mycophenolic Acid 2Melphalan 2Etoposide 2Blood Specimen Collection 2Aprepitant 2fludarabine 1dexamethasone acetate 1dexamethasone 21-phosphate 1Ultraviolet Therapy 1Thiotepa 1Thalidomide 1Tai Ji 1Surveys and Questionnaires 1Restraint, Physical 1Resistance Training 1Polymerase Chain Reaction 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Neoplasms, Plasma Cell × Heptavalent Pneumococcal Conjugate Vaccine × Clear all
NCT00569309 2018-03-12

Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma

Ohio State University Comprehensive Cancer Center

Phase NA Completed
30 enrolled 8 charts
LymphoidPlasma cell

Hodgkin Disease, Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, Follicular, Multiple Myeloma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Mantle-Cell, Neoplasms, Plasma Cell, Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡